Immunome Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immunome (NASDAQ:IMNM) Stock Price Down 4%

Immunome (NASDAQ:IMNM) Stock Price Down 4%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Leerink partnrsJpmorgan chase coImmunome company profileJanus henderson groupPricet rowe associates incVanguard group incRedmile groupImmunome incGet free reportTrading downHenderson groupAvidity partners managementImmunome daily

Immunome (NASDAQ:IMNM) Earns Outperform Rating from Wedbush

Immunome (NASDAQ:IMNM) Earns Outperform Rating from Wedbush
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Leerink partnrsJpmorgan chase coAcadian asset managementJump financialSei investments coImmunome incEntrypoint capitalDorsey wright associatesFree reportGet free reportPoint capitalAsset managementSei investmentsImmunome daily

JPMorgan Chase & Co Initiates Coverage on Immunome (NASDAQ:IMNM)

JPMorgan Chase & Co. assumed coverage on shares of Immunome (NASDAQ:IMNM – Free Report) in a research note published on Tuesday, Marketbeat reports. The firm issued an overweight rating and a $24.00 price objective on the stock. IMNM has been the subject of several other reports. Guggenheim initiated coverage on Immunome in a report on […]

Leerink partnrsTd asset management incImmunome company profileJpmorgan chase coImmunome incCerity partnersFree reportGet free reportPartners managementManagement incImmunome dailyNasdaq imnmInitiated coverageJpmorgan chase co

Immunome (NASDAQ:IMNM) Now Covered by Analysts at Guggenheim

Guggenheim assumed coverage on shares of Immunome (NASDAQ:IMNM – Free Report) in a report issued on Monday, Marketbeat Ratings reports. The firm issued a buy rating and a $35.00 price objective on the stock. Several other equities analysts also recently commented on IMNM. Leerink Partnrs reiterated an outperform rating on shares of Immunome in a […]

Leerink partnrsImmunome incPricet rowe associates incVanguard group incTd asset management incFree reportMarketbeat ratingsTrading downPartners managementManagement incGet free reportImmunome daily

Guggenheim Begins Coverage on Immunome (NASDAQ:IMNM)

Guggenheim initiated coverage on shares of Immunome (NASDAQ:IMNM – Free Report) in a report issued on Monday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $35.00 target price on the stock. Several other equities analysts have also issued reports on IMNM. Wedbush boosted their price target on Immunome from $27.00 to […]

Leerink partnrsRenaissance technologiesImmunome incDorsey wright associatesFirst republic investment management incFree reportMarketbeat ratingsRepublic investment managementGet free reportImmunome daily